Gene therapies

Ocular applications of gene therapies are increasing, as is our understanding of the molecular pathogenesis of glaucoma.

Ocular applications of gene therapies are increasing, as is our understanding of the molecular pathogenesis of glaucoma. In the Survey of Ophthalmology (Vol 54, No 4) Xuyanf Lie et al., look at Gene Therapy Targeting Glaucoma: Where Are We? and concludes: "Improvements in gene delivery techniques, refinement of vector construction methods, and development of better animal models combine to bring this potential therapy closer to reality."

Related Videos
Disrupting the glaucoma treatment paradigm with novel femtosecond laser from ViaLase
2-year data in contralateral eye evaluation gives edge to iStent inject over Hydrus stent
Should endocyclophotocoagulation be considered part of MIGS? Mr Ratnarajan delves in
Investigating the effects of canaloplasty on corneal epithelium
Related Content
© 2023 MJH Life Sciences

All rights reserved.